One-year mortality in coagulase-negative Staphylococcus and Staphylococcus aureus infective endocarditis

The aim of this study was to investigate in-hospital mortality and 12-month mortality in patients with coagulase-negative Staphylococcus (CoNS) compared to Staphylococcus aureus (S. aureus) infective endocarditis (IE). We used a prospective cohort study of 66 consecutive CoNS and 170 S. aureus IE patients, collected at 2 tertiary university hospitals in Copenhagen (Denmark) and at 1 tertiary university hospital in Gothenburg (Sweden). Median (range) C-reactive protein at admission was higher in patients with S. aureus IE (150 mg/l (1–521) vs 94 mg/l (6–303); p<0.001), which may suggest a more serous infection. CoNS was associated with prosthetic valve IE (49% vs 24%; p<0.001) and median diagnostic delay was longer in CoNS IE patients (20 d (0–232) vs 9 d (0–132); p<0.001). In-hospital mortality was equally high in both groups but 25% of the CoNS IE patients had died after 1 y compared to 39% of patients with S. aureus IE (p =0.05). In conclusion, CoNS IE was associated with a long diagnostic delay and high in-hospital mortality, whereas post-discharge prognosis was better in this group of patients compared to patients with IE due to S. aureus.

[1]  S. A. Pedersen,et al.  [Infectious endocarditis in the county of Frederiksborg, 1990-2000. Clinical findings and prognostic aspects]. , 2004, Ugeskrift for laeger.

[2]  P. Bossuyt,et al.  Prognostic value of serial C-reactive protein measurements in left-sided native valve endocarditis. , 2008, Archives of internal medicine.

[3]  C. Woods,et al.  Global Perspective Staphylococci Causing Endocarditis: a Genotypic Diversity of Coagulase-negative , 2008 .

[4]  B. Hoen,et al.  Prosthetic valve endocarditis due to coagulase-negative staphylococci: findings from the International Collaboration on Endocarditis Merged Database , 2006, European Journal of Clinical Microbiology and Infectious Diseases.

[5]  V. Fowler,et al.  Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  L. Olaison,et al.  Epidemiologic Aspects of Infective Endocarditis in an Urban Population: A 5‐Year Prospective Study , 1995, Medicine.

[7]  Vance G Fowler,et al.  Changing patient characteristics and the effect on mortality in endocarditis. , 2002, Archives of internal medicine.

[8]  G. Peters,et al.  Pathogenesis of infections due to coagulase-negative staphylococci. , 2002, The Lancet. Infectious diseases.

[9]  Bruno Hoen,et al.  Staphylococcus aureus native valve infective endocarditis: report of 566 episodes from the International Collaboration on Endocarditis Merged Database. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  Bruno Hoen,et al.  Emergence of coagulase-negative staphylococci as a cause of native valve endocarditis. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  D Raoult,et al.  Echocardiography predicts embolic events in infective endocarditis. , 2001, Journal of the American College of Cardiology.

[12]  R. Hasbún,et al.  Non-epidermidis coagulase-negative staphylococcal bacteremia: clinical predictors of true bacteremia , 2004, European Journal of Clinical Microbiology and Infectious Diseases.

[13]  G. Gottlieb,et al.  Infective endocarditis due to Staphylococcus aureus: 59 prospectively identified cases with follow-up. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  L. Olaison,et al.  Infective endocarditis: a diagnostic and therapeutic challenge for the new millennium. , 2000, Scandinavian journal of infectious diseases.

[15]  Gilbert Habib,et al.  Predictors of death and impact of surgery in Staphylococcus aureus infective endocarditis. , 2007, The Annals of thoracic surgery.

[16]  Gilbert Habib,et al.  Native valve endocarditis due to coagulase-negative staphylococci: report of 99 episodes from the International Collaboration on Endocarditis Merged Database. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[17]  H. Nissen,et al.  Native valve infective endocarditis in the general population: a 10-year survey of the clinical picture during the 1980s. , 1992, European heart journal.

[18]  N. Høiby,et al.  Bacterial Endocarditis at a Tertiary Hospital – How Do We Improve Diagnosis and Delay of Treatment? , 1998, Cardiology.

[19]  S. Goldstein,et al.  Seven cases of surgical native valve endocarditis caused by coagulase-negative staphylococci: An underappreciated disease. , 2001, American heart journal.

[20]  David R. Snydman,et al.  Staphylococcus aureus Native Valve Infective Endocarditis: Report of 566 Episodes From the International Collaboration on Endocarditis Merged DatabaseMiro JM, and the International Collaboration on Endocarditis Merged Database Study Group (Univ of Barcelona; et al) Clin Infect Dis 41:507–514, 2005§ , 2006 .

[21]  Ian E. Alexander,et al.  Fibroblasts Can Be Genetically Modified to Produce Excitable Cells Capable of Electrical Coupling , 2005, Circulation.

[22]  Patricia Muñoz,et al.  Contemporary clinical profile and outcome of prosthetic valve endocarditis. , 2007, JAMA.

[23]  P. Nihoyannopoulos,et al.  Duration of symptoms and the effects of a more aggressive surgical policy: two factors affecting prognosis of infective endocarditis. , 1985, European Heart Journal.

[24]  Panos Vardas,et al.  Guidelines on prevention, diagnosis and treatment of infective endocarditis executive summary; the task force on infective endocarditis of the European society of cardiology. , 2004, European heart journal.

[25]  Destructive native valve endocarditis caused by Staphylococcus lugdunensis. , 1999, Southern medical journal.

[26]  G. Baron,et al.  Infective endocarditis in Europe: lessons from the Euro heart survey , 2003, Heart.

[27]  L. Olaison,et al.  Fever, C-reactive protein, and other acute-phase reactants during treatment of infective endocarditis. , 1997, Archives of internal medicine.

[28]  Bruno Hoen,et al.  Changing profile of infective endocarditis: results of a 1-year survey in France. , 2002, JAMA.

[29]  S. Andreas,et al.  Clinical outcome and echocardiographic findings of native and prosthetic valve endocarditis in the 1990s , 1996 .

[30]  S. Eykyn,et al.  Increase in native valve endocarditis caused by coagulase negative staphylococci: an Anglo-French clinical and microbiological study. , 1990, British heart journal.